Tumor Antigen

Transduction of human dendritic cells with adenovirus encoding anti-PD-1 reduces PD-1 expression on co-cultured T cells
Santos Patricia, Etheridge Alexander, Andrea Gambotto, Lisa H Butterfield

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P254; DOI: 10.1186/2051-1426-2-S3-P254
Tri-functional T cell receptor antigen coupler (Tri-TAC): a novel method to direct T cells against tumors
Christopher Helsen, Ben Li, Galina Denisova, Jonathan L Bramson

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P17; DOI: 10.1186/2051-1426-2-S3-P17
A Phase I/II study of vesigenurtacel-l (hs-410) or placebo in combination with Bacillus Calmette-Guérin (BCG) in patients with non-muscle invasive bladder cancer (NMIBC)
Gary D Steinberg, Neal Shore, Lawrence Karsh, James Bailen, Michael Woods, Mark Schoenberg, Taylor H Schreiber, Melissa Price

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P81; DOI: 10.1186/2051-1426-2-S3-P81
Pre-operative immunotherapy with tumor cryoablation (cryo) plus ipilimumab (ipi) induces potentially favorable systemic and intratumoral immune effects in early stage breast cancer (ESBC) patients
David B Page, Adi Diab, Jianda Yuan, Zhiwan Dong, Stephen B Soloman, Sujata Patil, Clifford A Hudis, Jedd D Wolchok, Larry Norton, Heather L McArthur

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 1) O6; DOI: 10.1186/2051-1426-3-S1-O6
Adoptive immunotherapy with engineered T cells expressing and HLA-A2 restricted affinity-enhanced TCR for LAGE-1 and NY-ESO-1 in patients with multiple myeloma following auto-SCT
Aaron P Rapoport, Edward A Stadtmauer, Dan T Vogl, Brendan Weiss, Gwendolyn K Binder-Scholl, Dominic P Smethurst, Jeffrey Finklestein, Irina Kulikovskaya, Minnal Gupta, Joanna E Brewer, Alan D Bennett, Andrew B Gerry, Nick J Pumphrey, Helen K Tayton-Martin, Lilliam Ribeiro, Ashraf Z Badros, Saul Yanovich, Gorgun Akpek, Naseem Kerr, Sunita Philip, Sandra Westphal, Levine L Bruce, Bent K Jakobsen, Carl H June, Michael Kalos

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P30; DOI: 10.1186/2051-1426-1-S1-P30
Autologous whole-tumor antigen vaccination in combination with adoptive T cell therapy for patients with recurrent ovarian cancer
Lana E Kandalaft, Cheryl Chiang, Emese Zsiros, Janos Tanyi, Daniel Powell, Rosemarie Mick, George Coukos

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P220; DOI: 10.1186/2051-1426-1-S1-P220
Ganglioside containing nano-proteoliposome dampens myeloid-derived suppressor cells function and ability to cross-present tumor antigens: a new approach to recover CTL function on tumor bearing individuals
Audry Fernández, Liliana Oliver, Maura Rábade-Chediak, Rydell Alvarez, Arletty Hernández, Leslie Pérez, Luis E Fernández, Circe Mesa

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P225; DOI: 10.1186/2051-1426-1-S1-P225
T cell stimulation by dendritic cell-tumor cell hybrids is enhanced in the presence of free dendritic cells
Mariana P Pinho, Patricia C Bergami-Santos, José Alexandre M Barbuto

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P232; DOI: 10.1186/2051-1426-1-S1-P232
Expression of neuropilin-1 on in vivo induced regulatory T cells
Christopher J Nirschl, Christina Ceccato, Angela Alme, Brian Francica, Charles G Drake

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P167; DOI: 10.1186/2051-1426-1-S1-P167
Vaccination with pre-diagnostic tumor antigens but not established tumor antigens inhibits spontaneous tumorigenesis in TgMMTV-neu mice
Sasha E Stanton, Jianning Mao, John Ladd, Lauren Rastedder, Ekram Gad, Samir Hanash, Hailing Lu, Mary L Disis

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P237; DOI: 10.1186/2051-1426-1-S1-P237

Main menu

Tumor Antigen

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Tumor Antigen

Pages